Antibodies Assay Kits Biology Cells Brd4 Antibody Muc2 Antibody NATtrol Nedd4 Antibody Nox1 Antibody Panel Particles PCR Pcr Kits Peptides Vector & Virus Vi Alpha Vitronectin Antibody Western Blot Zebrafish Antibodies
Glycolysis-related gene expression profiling serves as a novel prognosis risk predictor for human hepatocellular carcinoma
Metabolic sample reconstruction is a vital think about tumor development. Metabolism of tumor cells is characterised by irregular enhance in anaerobic glycolysis, no matter excessive oxygen focus, leading to a major accumulation of power from glucose sources.
These adjustments promotes speedy cell proliferation and tumor development, which is additional referenced a course of generally known as the Warburg impact. The present examine reconstructed the metabolic sample in development of most cancers to determine genetic adjustments particular in most cancers cells. A complete of 12 widespread kinds of stable tumors have been included within the present examine.
Gene set enrichment evaluation (GSEA) was carried out to research 9 glycolysis-related gene units, that are implicated within the glycolysis course of. Univariate and multivariate analyses have been used to determine unbiased prognostic variables for building of a nomogram based mostly on clinicopathological traits and a glycolysis-related gene prognostic index (GRGPI).
The prognostic mannequin based mostly on glycolysis genes confirmed excessive space beneath the curve (AUC) in LIHC (Liver hepatocellular carcinoma). The findings of the present examine confirmed that eight genes (AURKA, CDK1, CENPA, DEPDC1, HMMR, KIF20A, PFKFB4, STMN1) have been correlated with total survival (OS) and recurrence-free survival (RFS).
Additional evaluation confirmed that the prediction mannequin precisely distinguished between high- and low-risk most cancers sufferers amongst sufferers in several clusters in LIHC. A nomogram with a well-fitted calibration curve based mostly on gene expression profiles and medical traits confirmed good discrimination based mostly on inner and exterior cohorts. These findings point out that adjustments in expression degree of metabolic genes implicated in glycolysis can contribute to reconstruction of tumor-related microenvironment.
Modifications in Methylation Patterns of Tumor Suppressor Genes throughout Prolonged Human Embryonic Stem Cell Cultures
Whereas research on embryonic stem cells have been actively carried out, little is understood in regards to the epigenetic mechanisms in human embryonic stem cells (hESCs) in prolonged tradition methods. Right here, we investigated whether or not CpG island (CGI) methylation patterns of 24 tumor suppressor genes could possibly be maintained throughout prolonged hESC cultures. In complete, 10 hESC strains have been analyzed.
For every cell line, genomic DNA was extracted from early and late passages of cell cultures. CGI methylation ranges of 24 tumor suppressor genes have been analyzed utilizing methylation-specific multiplex ligation-dependent probe amplification (MS-MLPA), pyrosequencing, and real-time polymerase chain response (PCR). Totally different CGI methylation patterns of CASP8, FHIT, and CHFR genes have been recognized in between early and late passages in some hESC strains.
CGI methylation ranges of CASP8 considerably elevated at late passage in CHA-36, CHA-40, and CHA-42 cell strains in comparison with these at early passage. The CGI methylation of the FHIT gene was greater at late passage than at early passage in CHA-15, CHA-31, CHA-32, and iPS (FS)-1 cell strains however decreased on the late passage in CHA-20 and H1 cell strains.
Totally different CGI methylation patterns have been detected for the CHFR gene solely in iPS (FS)-1, and the extent considerably elevated at late passage. Thus, our findings present that CGI methylation patterns could possibly be altered throughout extended ESC cultures and analyzing these epigenetic adjustments is vital to evaluate the upkeep, differentiation, and medical utilization of stem cells.
A genetic danger rating utilizing human chromosomal-scale size variation can predict schizophrenia
Research point out that schizophrenia has a genetic part, nevertheless it can’t be remoted to a single gene. We aimed to find out how nicely one might predict that an individual will develop schizophrenia based mostly on their germ line genetics. We in contrast 1129 folks from the UK Biobank dataset who had a prognosis of schizophrenia to an equal variety of age matched folks drawn from the overall UK Biobank inhabitants.
For every particular person, we constructed a profile consisting of numbers. Every quantity characterised the size of segments of chromosomes. We examined a number of machine studying algorithms to find out which was simplest in predicting schizophrenia and if any enchancment in prediction happens by breaking the chromosomes into smaller chunks.
We discovered that the stacked ensemble, carried out greatest with an space beneath the receiver working attribute curve (AUC) of 0.545 (95% CI 0.539-0.550). We famous a rise within the AUC by breaking the chromosomes into smaller chunks for evaluation. Utilizing SHAP values, we recognized the X chromosome as a very powerful contributor to the predictive mannequin. We conclude that germ line chromosomal scale size variation knowledge might present an efficient genetic danger rating for schizophrenia which performs higher than probability.
Clinically important findings of high-risk mutations in human SLC29A4 gene related to diabetes mellitus kind 2 in Pakistani inhabitants
This examine carried out an in-depth evaluation combining computational and experimental verifications of the deleterious missense mutations related to the SLC29A4 protein. The purposeful annotation of the non-synonymous single nucleotide polymorphism (nsSNPs), adopted by structure-function evaluation, revealed 13 single nucleotide polymorphisms (SNP) as probably the most damaging.
Amongst these, six mutants P429T/S, L144S, M108V, N86H, and V79E, have been predicted as structurally and functionally damaging by protein stability evaluation. Additionally, these variants are situated at evolutionary conserved areas, both buried, contributing to the structural injury, or uncovered, inflicting purposeful adjustments within the protein.
These mutants have been additional taken for molecular docking research. When verified by way of experimental evaluation, the SNPs M108V (rs149798710), N86H (rs151039853), and V79E (rs17854505) confirmed an affiliation with kind 2 diabetes mellitus (T2DM). Minor allele frequency for rs149798710 (A > G) was 0.23 in controls, 0.29 in metformin responders, 0.37 in metformin non-responder, for rs151039853 (A > C) was 0.21 in controls, 0.28 in metformin responders, 0.36 in metformin non-responder and for rs17854505 (T > A) was 0.20 in controls, 0.25 in metformin responders, 0.37 in metformin non-responder.
Genome polyprotein Antibody (Biotin) |
|||
| 20-abx106264 | Abbexa |
|
|
Genome polyprotein Antibody (FITC) |
|||
| 20-abx107678 | Abbexa |
|
|
Genome polyprotein Antibody (HRP) |
|||
| 20-abx109095 | Abbexa |
|
|
Genome Polyprotein Polyclonal Antibody |
|||
| A56130 | EpiGentek | 100 µg | EUR 570.55 |
|
Description: Ask the seller for details |
|||
Genome Polyprotein Polyclonal Antibody |
|||
| A56743 | EpiGentek | 100 µg | EUR 570.55 |
|
Description: Ask the seller for details |
|||
Genome Polyprotein Polyclonal Antibody |
|||
| A68253 | EpiGentek | 100 µg | EUR 570.55 |
|
Description: Ask the seller for details |
|||
Genome Polyprotein Polyclonal Antibody |
|||
| A68254 | EpiGentek | 100 µg | EUR 570.55 |
|
Description: reagents widely cited |
|||
Genome polyprotein Antibody (HRP) |
|||
| 20-abx300968 | Abbexa |
|
|
Genome polyprotein Antibody (FITC) |
|||
| 20-abx300969 | Abbexa |
|
|
Genome polyprotein Antibody (Biotin) |
|||
| 20-abx300970 | Abbexa |
|
|
Genome polyprotein Antibody, HRP conjugated |
|||
| 1-CSB-PA333180LB01HFD | Cusabio |
|
|
|
Description: A polyclonal antibody against Genome polyprotein. Recognizes Genome polyprotein from Hepatitis C virus genotype 1a. This antibody is HRP conjugated. Tested in the following application: ELISA |
|||
Genome polyprotein Antibody, FITC conjugated |
|||
| 1-CSB-PA333180LC01HFD | Cusabio |
|
|
|
Description: A polyclonal antibody against Genome polyprotein. Recognizes Genome polyprotein from Hepatitis C virus genotype 1a. This antibody is FITC conjugated. Tested in the following application: ELISA |
|||
Genome polyprotein Antibody, Biotin conjugated |
|||
| 1-CSB-PA333180LD01HFD | Cusabio |
|
|
|
Description: A polyclonal antibody against Genome polyprotein. Recognizes Genome polyprotein from Hepatitis C virus genotype 1a. This antibody is Biotin conjugated. Tested in the following application: ELISA |
|||
Genome polyprotein Antibody, HRP conjugated |
|||
| 1-CSB-PA714772LB01HYH | Cusabio |
|
|
|
Description: A polyclonal antibody against Genome polyprotein. Recognizes Genome polyprotein from Human enterovirus 71. This antibody is HRP conjugated. Tested in the following application: ELISA |
|||
Genome polyprotein Antibody, FITC conjugated |
|||
| 1-CSB-PA714772LC01HYH | Cusabio |
|
|
|
Description: A polyclonal antibody against Genome polyprotein. Recognizes Genome polyprotein from Human enterovirus 71. This antibody is FITC conjugated. Tested in the following application: ELISA |
|||
Genome polyprotein Antibody, Biotin conjugated |
|||
| 1-CSB-PA714772LD01HYH | Cusabio |
|
|
|
Description: A polyclonal antibody against Genome polyprotein. Recognizes Genome polyprotein from Human enterovirus 71. This antibody is Biotin conjugated. Tested in the following application: ELISA |
|||
Genome polyprotein Antibody, HRP conjugated |
|||
| 1-CSB-PA18549B0Rb | Cusabio |
|
|
|
Description: A polyclonal antibody against Genome polyprotein. Recognizes Genome polyprotein from Dengue virus. This antibody is HRP conjugated. Tested in the following application: ELISA |
|||
Genome polyprotein Antibody, FITC conjugated |
|||
| 1-CSB-PA18549C0Rb | Cusabio |
|
|
|
Description: A polyclonal antibody against Genome polyprotein. Recognizes Genome polyprotein from Dengue virus. This antibody is FITC conjugated. Tested in the following application: ELISA |
|||
Genome polyprotein Antibody, Biotin conjugated |
|||
| 1-CSB-PA18549D0Rb | Cusabio |
|
|
|
Description: A polyclonal antibody against Genome polyprotein. Recognizes Genome polyprotein from Dengue virus. This antibody is Biotin conjugated. Tested in the following application: ELISA |
|||
Human rhinovirus 1A Genome polyprotein |
|||
| 1-CSB-YP326367HQA | Cusabio |
|
|
|
Description: Recombinant Human rhinovirus 1A Genome polyprotein,partial expressed in Yeast |
|||
Japanese encephalitis virus Genome polyprotein |
|||
| 1-CSB-EP189574Ba | Cusabio |
|
|
|
Description: Recombinant Japanese encephalitis virus Genome polyprotein,partial expressed in E.coli |
|||
Yellow fever virus Genome polyprotein |
|||
| 1-CSB-EP365905YAC1 | Cusabio |
|
|
|
Description: Recombinant Yellow fever virus Genome polyprotein,partial expressed in E.coli |
|||
Genome polyprotein Antibody, HRP conjugated |
|||
| 1-CSB-PA362073LB01HQD | Cusabio |
|
|
|
Description: A polyclonal antibody against Genome polyprotein. Recognizes Genome polyprotein from Human rhinovirus A serotype 89. This antibody is HRP conjugated. Tested in the following application: ELISA |
|||
Genome polyprotein Antibody, FITC conjugated |
|||
| 1-CSB-PA362073LC01HQD | Cusabio |
|
|
|
Description: A polyclonal antibody against Genome polyprotein. Recognizes Genome polyprotein from Human rhinovirus A serotype 89. This antibody is FITC conjugated. Tested in the following application: ELISA |
|||
Genome polyprotein Antibody, Biotin conjugated |
|||
| 1-CSB-PA362073LD01HQD | Cusabio |
|
|
|
Description: A polyclonal antibody against Genome polyprotein. Recognizes Genome polyprotein from Human rhinovirus A serotype 89. This antibody is Biotin conjugated. Tested in the following application: ELISA |
|||
Genome Polyprotein (HCV-Core) Antibody |
|||
| 33487-05111 | AssayPro | 150 ug | EUR 261 |
Enterovirus 71 Genome polyprotein Antibody |
|||
| 20-abx109758 | Abbexa |
|
|
Recombinant JEV Genome polyprotein (aa 2528-3432) Protein |
|||
| VAng-Wyb3447-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 8272 |
|
Description: Japanese encephalitis virus (strain Jaoars982) Genome polyprotein, recombinant protein. |
|||
Recombinant YFV Genome polyprotein Protein (aa 286-730) |
|||
| VAng-Cr6541-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 4793 |
|
Description: YFV Genome polyprotein, partial, recombinant protein. |
|||
Recombinant YFV Genome polyprotein Protein (aa 286-730) |
|||
| VAng-Cr6541-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 3048 |
|
Description: YFV Genome polyprotein, partial, recombinant protein. |
|||
Recombinant YFV Genome polyprotein Protein (aa 286-730) |
|||
| VAng-Cr6541-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 903 |
|
Description: YFV Genome polyprotein, partial, recombinant protein. |
|||
Recombinant YFV Genome polyprotein Protein (aa 1-101) |
|||
| VAng-Cr6542-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 2840 |
|
Description: YFV Genome polyprotein, recombinant protein. |
|||
Recombinant YFV Genome polyprotein Protein (aa 1-101) |
|||
| VAng-Cr6542-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 2044 |
|
Description: YFV Genome polyprotein, recombinant protein. |
|||
Recombinant YFV Genome polyprotein Protein (aa 1-101) |
|||
| VAng-Cr6542-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 1411 |
|
Description: YFV Genome polyprotein, recombinant protein. |
|||
Recombinant Human Genome polyprotein, His, Yeast-100ug |
|||
| QP7370-ye-100ug | EnQuireBio | 100ug | EUR 480 |
Recombinant Human Genome polyprotein, His, Yeast-10ug |
|||
| QP7370-ye-10ug | EnQuireBio | 10ug | EUR 236 |
Recombinant Human Genome polyprotein, His, Yeast-1mg |
|||
| QP7370-ye-1mg | EnQuireBio | 1mg | EUR 1885 |
Recombinant Human Genome polyprotein, His, Yeast-200ug |
|||
| QP7370-ye-200ug | EnQuireBio | 200ug | EUR 744 |
Recombinant Human Genome polyprotein, His, Yeast-500ug |
|||
| QP7370-ye-500ug | EnQuireBio | 500ug | EUR 1206 |
Recombinant Human Genome polyprotein, His, Yeast-50ug |
|||
| QP7370-ye-50ug | EnQuireBio | 50ug | EUR 299 |
Recombinant YFV Genome polyprotein (NS4A) Protein (aa 1-3412) |
|||
| VAng-Cr6545-inquire | Creative Biolabs | inquire | Ask for price |
|
Description: YFV (isolate Uganda/A7094A4/1948) Genome polyprotein (NS4A), recombinant protein. |
|||
Enterovirus 71 Genome polyprotein Antibody (FITC) |
|||
| 20-abx106801 | Abbexa |
|
|
Enterovirus 71 Genome polyprotein Antibody (HRP) |
|||
| 20-abx108220 | Abbexa |
|
|
Enterovirus 71 Genome polyprotein Antibody (Biotin) |
|||
| 20-abx105382 | Abbexa |
|
|
Genome Polyprotein Polyclonal Antibody, HRP Conjugated |
|||
| A56131 | EpiGentek | 100 µg | EUR 570.55 |
|
Description: The best epigenetics products |
|||
Genome Polyprotein Polyclonal Antibody, FITC Conjugated |
|||
| A56132 | EpiGentek | 100 µg | EUR 570.55 |
|
Description: kits suitable for this type of research |
|||
Genome Polyprotein Polyclonal Antibody, Biotin Conjugated |
|||
| A56133 | EpiGentek | 100 µg | EUR 570.55 |
|
Description: fast delivery possible |
|||
Genome Polyprotein Polyclonal Antibody, HRP Conjugated |
|||
| A56744 | EpiGentek | 100 µg | EUR 570.55 |
|
Description: The best epigenetics products |
|||
Genome Polyprotein Polyclonal Antibody, FITC Conjugated |
|||
| A56745 | EpiGentek | 100 µg | EUR 570.55 |
|
Description: kits suitable for this type of research |
|||
Genome Polyprotein Polyclonal Antibody, Biotin Conjugated |
|||
| A56746 | EpiGentek | 100 µg | EUR 570.55 |
|
Description: fast delivery possible |
|||
Genome Polyprotein Polyclonal Antibody, Biotin Conjugated |
|||
| A68250 | EpiGentek | 100 µg | EUR 570.55 |
|
Description: reagents widely cited |
|||
Genome Polyprotein Polyclonal Antibody, FITC Conjugated |
|||
| A68251 | EpiGentek | 100 µg | EUR 570.55 |
|
Description: Ask the seller for details |
|||
Genome Polyprotein Polyclonal Antibody, HRP Conjugated |
|||
| A68252 | EpiGentek | 100 µg | EUR 570.55 |
|
Description: The best epigenetics products |
|||
Genome Polyprotein Polyclonal Antibody, HRP Conjugated |
|||
| A68255 | EpiGentek | 100 µg | EUR 570.55 |
|
Description: Ask the seller for details |
|||
Genome Polyprotein Polyclonal Antibody, FITC Conjugated |
|||
| A68256 | EpiGentek | 100 µg | EUR 570.55 |
|
Description: The best epigenetics products |
|||
Genome Polyprotein Polyclonal Antibody, Biotin Conjugated |
|||
| A68257 | EpiGentek | 100 µg | EUR 570.55 |
|
Description: kits suitable for this type of research |
|||
Recombinant Human Genome polyprotein, His-SUMO, E.coli-100ug |
|||
| QP7370-ec-100ug | EnQuireBio | 100ug | EUR 408 |
Recombinant Human Genome polyprotein, His-SUMO, E.coli-10ug |
|||
| QP7370-ec-10ug | EnQuireBio | 10ug | EUR 200 |
Recombinant Human Genome polyprotein, His-SUMO, E.coli-1mg |
|||
| QP7370-ec-1mg | EnQuireBio | 1mg | EUR 1632 |
Recombinant Human Genome polyprotein, His-SUMO, E.coli-200ug |
|||
| QP7370-ec-200ug | EnQuireBio | 200ug | EUR 634 |
Recombinant Human Genome polyprotein, His-SUMO, E.coli-500ug |
|||
| QP7370-ec-500ug | EnQuireBio | 500ug | EUR 1060 |
Recombinant Human Genome polyprotein, His-SUMO, E.coli-50ug |
|||
| QP7370-ec-50ug | EnQuireBio | 50ug | EUR 263 |
Hepatitis C virus genotype 1b Genome polyprotein |
|||
| 1-CSB-YP530838HVQ(A3) | Cusabio |
|
|
|
Description: Recombinant Hepatitis C virus genotype 1b Genome polyprotein,partial expressed in Yeast |
|||
Hepatitis C virus genotype 1b Genome polyprotein |
|||
| 1-CSB-YP530838HVQ(A4) | Cusabio |
|
|
|
Description: Recombinant Hepatitis C virus genotype 1b Genome polyprotein,partial expressed in Yeast |
|||
Human rhinovirus A serotype 89 Genome polyprotein |
|||
| 1-CSB-YP362073HQD | Cusabio |
|
|
|
Description: Recombinant Human rhinovirus A serotype 89 Genome polyprotein,partial expressed in Yeast |
|||
Hepatitis C virus genotype 1a Genome polyprotein |
|||
| 1-CSB-MP333180HFD | Cusabio |
|
|
|
Description: Recombinant Hepatitis C virus genotype 1a Genome polyprotein,partial expressed in Mammalian cell |
|||
Hepatitis C virus genotype 1a Genome polyprotein |
|||
| 1-CSB-EP333180HFD | Cusabio |
|
|
|
Description: Recombinant Hepatitis C virus genotype 1a Genome polyprotein,partial expressed in E.coli |
|||
Human rhinovirus A serotype 89 Genome polyprotein |
|||
| 1-CSB-EP362073HQD | Cusabio |
|
|
|
Description: Recombinant Human rhinovirus A serotype 89 Genome polyprotein,partial expressed in E.coli |
|||
Human rhinovirus A serotype 89 Genome polyprotein |
|||
| 1-CSB-EP362073HQDb0 | Cusabio |
|
|
|
Description: Recombinant Human rhinovirus A serotype 89 Genome polyprotein,partial expressed in E.coli |
|||
Genome Polyprotein (HCV-Core) Antibody (Biotin Conjugate) |
|||
| 33487-05121 | AssayPro | 150 ug | EUR 369 |
Rhinovirus A serotype 89 Genome polyprotein Antibody |
|||
| 20-abx109372 | Abbexa |
|
|
Genome Polyprotein (HCV-Core) AssayLite Antibody (FITC Conjugate) |
|||
| 33487-05141 | AssayPro | 150 ug | EUR 428 |
Genome Polyprotein (HCV-Core) AssayLite Antibody (RPE Conjugate) |
|||
| 33487-05151 | AssayPro | 150 ug | EUR 428 |
Genome Polyprotein (HCV-Core) AssayLite Antibody (APC Conjugate) |
|||
| 33487-05161 | AssayPro | 150 ug | EUR 428 |
Genome Polyprotein (HCV-Core) AssayLite Antibody (PerCP Conjugate) |
|||
| 33487-05171 | AssayPro | 150 ug | EUR 471 |
Rhinovirus A serotype 89 Genome polyprotein Antibody (FITC) |
|||
| 20-abx107303 | Abbexa |
|
|
Rhinovirus A serotype 89 Genome polyprotein Antibody (HRP) |
|||
| 20-abx108723 | Abbexa |
|
|
Recombinant MAYV Structural polyprotein Protein |
|||
| VAng-Wyb3702-inquire | Creative Biolabs | inquire | Ask for price |
|
Description: Mayaro virus (strain Brazil) Structural polyprotein, recombinant protein. |
|||
Recombinant CHIKV Structural Polyprotein |
|||
| VAng-Lsx0030-inquire | Creative Biolabs | inquire | Ask for price |
|
Description: CHIKV Structural Polyprotein, recombinant protein from E. coli. |
|||
Recombinant MLV Radiation Pol Polyprotein |
|||
| VAng-Lsx0414-inquire | Creative Biolabs | inquire | Ask for price |
|
Description: MLV Radiation Pol Polyprotein, recombinant protein from E. coli. |
|||
Recombinant CHIKV Non-structural Polyprotein |
|||
| VAng-Lsx0031-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 4168 |
|
Description: CHIKV Non-structural Polyprotein, recombinant protein from E. coli. |
|||
Recombinant CHIKV Non-structural Polyprotein |
|||
| VAng-Lsx0031-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 2788 |
|
Description: CHIKV Non-structural Polyprotein, recombinant protein from E. coli. |
|||
Recombinant JEV Polyprotein NS5 (aa 2780-3428) Protein |
|||
| VAng-Wyb3462-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 3294 |
|
Description: Japanese encephalitis virus Polyprotein NS5 protein, recombinant protein. |
|||
Recombinant JEV Polyprotein NS5 (aa 2780-3428) Protein |
|||
| VAng-Wyb3462-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 2113 |
|
Description: Japanese encephalitis virus Polyprotein NS5 protein, recombinant protein. |
|||
Recombinant JEV Polyprotein NS5 (aa 2780-3428) Protein |
|||
| VAng-Wyb3462-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 573 |
|
Description: Japanese encephalitis virus Polyprotein NS5 protein, recombinant protein. |
|||
Recombinant MAYV NS polyprotein Protein (aa 1005-1327) |
|||
| VAng-Wyb3703-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 4655 |
|
Description: Mayaro virus (strain Brazil) Non-structural polyprotein, recombinant protein. |
|||
Recombinant MAYV NS polyprotein Protein (aa 1005-1327) |
|||
| VAng-Wyb3703-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 3034 |
|
Description: Mayaro virus (strain Brazil) Non-structural polyprotein, recombinant protein. |
|||
Recombinant MAYV Structural polyprotein Protein (aa 807-1242) |
|||
| VAng-Wyb3704-100g | Creative Biolabs | 100 µg | EUR 6897 |
|
Description: Mayaro virus (strain Brazil) Structural polyprotein, recombinant protein. |
|||
Recombinant MAYV Structural polyprotein Protein (aa 807-1242) |
|||
| VAng-Wyb3704-10g | Creative Biolabs | 10 µg | EUR 3005 |
|
Description: Mayaro virus (strain Brazil) Structural polyprotein, recombinant protein. |
|||
Recombinant MAYV Structural polyprotein Protein (aa 807-1242) |
|||
| VAng-Wyb3704-50g | Creative Biolabs | 50 µg | EUR 4394 |
|
Description: Mayaro virus (strain Brazil) Structural polyprotein, recombinant protein. |
|||
Recombinant JEV Polyprotein NS5 (aa 2780-3428) [His] Protein |
|||
| VAng-Wyb3463-1mg | Creative Biolabs | 1 mg | EUR 4985 |
|
Description: Japanese encephalitis virus Polyprotein NS5 protein, recombinant protein. |
|||
Recombinant JEV Polyprotein NS5 (aa 2780-3428) [His] Protein |
|||
| VAng-Wyb3463-500g | Creative Biolabs | 500 µg | EUR 3198 |
|
Description: Japanese encephalitis virus Polyprotein NS5 protein, recombinant protein. |
|||
Recombinant JEV Polyprotein NS5 (aa 2780-3428) [His] Protein |
|||
| VAng-Wyb3463-50g | Creative Biolabs | 50 µg | EUR 1013 |
|
Description: Japanese encephalitis virus Polyprotein NS5 protein, recombinant protein. |
|||
Sindbis virus Structural polyprotein |
|||
| 1-CSB-CF361018SHZ | Cusabio |
|
|
|
Description: Recombinant Sindbis virus Structural polyprotein,partial expressed in in vitro E.coli expression system |
|||
Sindbis virus Structural polyprotein |
|||
| 1-CSB-CF361018SHZb2 | Cusabio |
|
|
|
Description: Recombinant Sindbis virus Structural polyprotein,partial expressed in in vitro E.coli expression system |
|||
Turnip mosaic virus Polyprotein |
|||
| 1-CSB-EP2708TJM | Cusabio |
|
|
|
Description: Recombinant Turnip mosaic virus Polyprotein,partial expressed in E.coli |
|||
Gag Polyprotein (gag) Antibody |
|||
| 20-abx318946 | Abbexa |
|
|
Gag Polyprotein (gag) Antibody |
|||
| 20-abx317799 | Abbexa |
|
|
Structural Polyprotein (VP2) Antibody |
|||
| abx224337-100ug | Abbexa | 100 ug | EUR 411 |
Gag Polyprotein (GAG) Antibody |
|||
| abx331332-100ul | Abbexa | 100 ul | EUR 425 |
Recombinant Norwalk virus genome-linked protein Protein (aa 963–1100) [His] |
|||
| VAng-Wyb3659-100g | Creative Biolabs | 100 µg | EUR 3335 |
|
Description: Norwalk virus (strain GI/Human/United States/Norwalk/1968) genome-linked protein, recombinant protein. |
|||
Recombinant Norwalk virus genome-linked protein Protein (aa 963–1100) [His] |
|||
| VAng-Wyb3659-500g | Creative Biolabs | 500 µg | EUR 8162 |
|
Description: Norwalk virus (strain GI/Human/United States/Norwalk/1968) genome-linked protein, recombinant protein. |
|||
Recombinant hepatitis Non-structural polyprotein pORF1 Protein, His, E.coli-100ug |
|||
| QP7125-100ug | EnQuireBio | 100ug | EUR 771 |
Recombinant hepatitis Non-structural polyprotein pORF1 Protein, His, E.coli-10ug |
|||
| QP7125-10ug | EnQuireBio | 10ug | EUR 355 |
Recombinant hepatitis Non-structural polyprotein pORF1 Protein, His, E.coli-1mg |
|||
| QP7125-1mg | EnQuireBio | 1mg | EUR 2531 |
Recombinant hepatitis Non-structural polyprotein pORF1 Protein, His, E.coli-200ug |
|||
| QP7125-200ug | EnQuireBio | 200ug | EUR 1224 |
Recombinant hepatitis Non-structural polyprotein pORF1 Protein, His, E.coli-500ug |
|||
| QP7125-500ug | EnQuireBio | 500ug | EUR 1614 |
Recombinant hepatitis Non-structural polyprotein pORF1 Protein, His, E.coli-50ug |
|||
| QP7125-50ug | EnQuireBio | 50ug | EUR 473 |
Recombinant MMTV Gag Polyprotein (aa 2-99) [His] |
|||
| VAng-Lsx0591-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 3010 |
|
Description: Mouse Mammary Tumor Virus Gag Polyprotein (aa 2-99) [His], recombinant protein from E. coli. |
|||
Recombinant MMTV Gag Polyprotein (aa 2-99) [His] |
|||
| VAng-Lsx0591-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 2039 |
|
Description: Mouse Mammary Tumor Virus Gag Polyprotein (aa 2-99) [His], recombinant protein from E. coli. |
|||
Recombinant MMTV Gag Polyprotein (aa 2-99) [His] |
|||
| VAng-Lsx0591-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 1396 |
|
Description: Mouse Mammary Tumor Virus Gag Polyprotein (aa 2-99) [His], recombinant protein from E. coli. |
|||
Recombinant Hepatitis C Virus polyprotein, His, E.coli-100ug |
|||
| QP8939-ec-100ug | EnQuireBio | 100ug | EUR 707 |
Recombinant Hepatitis C Virus polyprotein, His, E.coli-10ug |
|||
| QP8939-ec-10ug | EnQuireBio | 10ug | EUR 326 |
Recombinant Hepatitis C Virus polyprotein, His, E.coli-1mg |
|||
| QP8939-ec-1mg | EnQuireBio | 1mg | EUR 2303 |
Recombinant Hepatitis C Virus polyprotein, His, E.coli-200ug |
|||
| QP8939-ec-200ug | EnQuireBio | 200ug | EUR 1115 |
Recombinant Hepatitis C Virus polyprotein, His, E.coli-500ug |
|||
| QP8939-ec-500ug | EnQuireBio | 500ug | EUR 1514 |
Recombinant Hepatitis C Virus polyprotein, His, E.coli-50ug |
|||
| QP8939-ec-50ug | EnQuireBio | 50ug | EUR 435 |
Genome edited iPSCs (KO) PARK2-/- |
|||
| ASE-9400 | Applied StemCell | 1 vial (1 x 10^6) | EUR 3087.5 |
|
Description: 12 month |
|||
Genome edited iPSCs (KO) PARK7-/- |
|||
| ASE-9401 | Applied StemCell | 1 vial (1 x 10^6) | EUR 3087.5 |
|
Description: 12 month |
|||
Genome edited iPSCs (KO) PINK1-/- |
|||
| ASE-9402 | Applied StemCell | 1 vial (1 x 10^6) | EUR 3087.5 |
|
Description: 12 month |
|||
Genome edited iPSCs (KO) LRRK2-/- |
|||
| ASE-9403 | Applied StemCell | 1 vial (1 x 10^6) | EUR 3087.5 |
|
Description: 12 month |
|||
Genome edited iPSCs (KO) BDNF-/- |
|||
| ASE-9404 | Applied StemCell | 1 vial (1 x 10^6) | EUR 3087.5 |
|
Description: 12 month |
|||
Genome edited iPSCs (KO) APOE-/- |
|||
| ASE-9405 | Applied StemCell | 1 vial (1 x 10^6) | EUR 3087.5 |
|
Description: 12 month |
|||
Genome edited iPSCs (KO) DISC1-/- |
|||
| ASE-9406 | Applied StemCell | 1 vial (1 x 10^6) | EUR 3087.5 |
|
Description: 12 month |
|||
Genome edited iPSCs (KO) SOD1-/- |
|||
| ASE-9407 | Applied StemCell | 1 vial (1 x 10^6) | EUR 3087.5 |
|
Description: 12 month |
|||
Genome edited iPSCs (KO) CNTNAP2-/- |
|||
| ASE-9408 | Applied StemCell | 1 vial (1 x 10^6) | EUR 3087.5 |
|
Description: 12 month |
|||
Gag Polyprotein (GAG) Antibody (Biotin) |
|||
| 20-abx106336 | Abbexa |
|
|
Gag Polyprotein (GAG) Antibody (FITC) |
|||
| 20-abx107749 | Abbexa |
|
|
Gag Polyprotein (GAG) Antibody (HRP) |
|||
| 20-abx318947 | Abbexa |
|
|
Gag Polyprotein (GAG) Antibody (FITC) |
|||
| 20-abx318948 | Abbexa |
|
|
Gag Polyprotein (GAG) Antibody (Biotin) |
|||
| 20-abx318949 | Abbexa |
|
|
Gag Polyprotein (GAG) Antibody (HRP) |
|||
| 20-abx317800 | Abbexa |
|
|
Gag Polyprotein (GAG) Antibody (FITC) |
|||
| 20-abx317801 | Abbexa |
|
|
Gag Polyprotein (GAG) Antibody (Biotin) |
|||
| 20-abx317802 | Abbexa |
|
|
Recombinant HTLV-2 gp 2 Gag-Pro-Pol Polyprotein |
|||
| VAng-Lsx0325-inquire | Creative Biolabs | inquire | Ask for price |
|
Description: HTLV-2 gp 2 Gag-Pro-Pol Polyprotein, recombinant protein from E. coli. |
|||
RecQ-Mediated Genome Instability Protein 1 (RMI1) Antibody |
|||
| 20-abx115306 | Abbexa |
|
|
RecQ-Mediated Genome Instability Protein 1 (RMI1) Antibody |
|||
| 20-abx318666 | Abbexa |
|
|
RecQ-Mediated Genome Instability Protein 1 (RMI1) Antibody |
|||
| 20-abx003807 | Abbexa |
|
|
RecQ-Mediated Genome Instability Protein 1 (RMI1) Antibody |
|||
| abx145095-100ug | Abbexa | 100 ug | EUR 391 |
RecQ-Mediated Genome Instability Protein 2 (RMI2) Antibody |
|||
| 20-abx005864 | Abbexa |
|
|
RecQ-Mediated Genome Instability Protein 1 (RMI1) Antibody |
|||
| abx029125-400ul | Abbexa | 400 ul | EUR 523 |
RecQ-Mediated Genome Instability Protein 1 (RMI1) Antibody |
|||
| abx029125-80l | Abbexa | 80 µl | EUR 286 |
RecQ-Mediated Genome Instability Protein 1 (RMI1) Antibody |
|||
| abx237321-100ug | Abbexa | 100 ug | EUR 551 |
Non-Structural Polyprotein Porf1 (ORF1) Antibody |
|||
| 20-abx300971 | Abbexa |
|
|
HIV-1 gag Polyprotein (121-140) |
|||
| H-4776.0500 | Bachem | 0.5mg | EUR 708 |
|
Description: Sum Formula: C86H138N26O34; CAS# [1815618-20-2] |
|||
HIV-1 gag Polyprotein (121-140) |
|||
| H-4776.1000 | Bachem | 1.0mg | EUR 1240 |
|
Description: Sum Formula: C86H138N26O34; CAS# [1815618-20-2] |
|||
RecQ-Mediated Genome Instability Protein 1 (RMI1) Antibody (HRP) |
|||
| 20-abx311381 | Abbexa |
|
|
RecQ-Mediated Genome Instability Protein 1 (RMI1) Antibody (FITC) |
|||
| 20-abx311382 | Abbexa |
|
|
RecQ-Mediated Genome Instability Protein 1 (RMI1) Antibody (Biotin) |
|||
| 20-abx311383 | Abbexa |
|
|
Rmi1 ELISA Kit| Mouse RecQ-mediated genome instability protein |
|||
| EF015197 | Lifescience Market | 96 Tests | EUR 689 |
Rmi2 ELISA Kit| Mouse RecQ-mediated genome instability protein |
|||
| EF016112 | Lifescience Market | 96 Tests | EUR 689 |
RMI1 ELISA Kit| Bovine RecQ-mediated genome instability protein |
|||
| EF011502 | Lifescience Market | 96 Tests | EUR 689 |
RMI2 ELISA Kit| Bovine RecQ-mediated genome instability protein |
|||
| EF011868 | Lifescience Market | 96 Tests | EUR 689 |
Mitochondrial Genome Maintenance Exonuclease 1 (MGME1) Antibody |
|||
| abx235168-100ug | Abbexa | 100 ug | EUR 509 |
Mitochondrial Genome Maintenance Exonuclease 1 (MGME1) Antibody |
|||
| 20-abx302859 | Abbexa |
|
|
Avian infectious bursal disease virus Structural polyprotein |
|||
| 1-CSB-RP182094V | Cusabio |
|
|
|
Description: Recombinant Avian infectious bursal disease virus Structural polyprotein,partial expressed in E.coli |
|||
Moloney murine leukemia virus Gag polyprotein (gag) |
|||
| 1-CSB-EP356017MHK | Cusabio |
|
|
|
Description: Recombinant Moloney murine leukemia virus Gag polyprotein(gag) ,partial expressed in E.coli |
|||
Moloney murine leukemia virus Gag polyprotein (gag) |
|||
| 1-CSB-EP356017MHKe0 | Cusabio |
|
|
|
Description: Recombinant Moloney murine leukemia virus Gag polyprotein(gag),partial expressed in E.coli |
|||
HIV-1 Gag-Pol polyprotein Antibody (Biotin) |
|||
| 20-abx106322 | Abbexa |
|
|
HIV-1 Gag-Pol polyprotein Antibody (FITC) |
|||
| 20-abx107735 | Abbexa |
|
|
HIV-1 Gag-Pol polyprotein Antibody (HRP) |
|||
| 20-abx109153 | Abbexa |
|
|
Moloney murine leukemia virus Gag polyprotein Antibody |
|||
| 20-abx110606 | Abbexa |
|
|
Pre-Glycoprotein Polyprotein GP Complex (GPC) Antibody |
|||
| 20-abx319921 | Abbexa |
|
|
Human RecQ-mediated genome instability protein 1 (RMI1) ELISA Kit |
|||
| abx382828-96tests | Abbexa | 96 tests | EUR 911 |
Mouse RecQ-mediated genome instability protein 1 (RMI1) ELISA Kit |
|||
| abx389563-96tests | Abbexa | 96 tests | EUR 911 |
Mouse RecQ-mediated genome instability protein 2 (RMI2) ELISA Kit |
|||
| abx390470-96tests | Abbexa | 96 tests | EUR 911 |
Therefore, this examine concludes that SLC29A4 M108V (rs149798710), N86H (rs151039853), and V79E (rs17854505) polymorphisms have been related to the elevated danger of T2DM in addition to with the elevated danger in direction of the failure of metformin therapeutic response in T2DM sufferers of Pakistan. Communicated by Ramaswamy H. Sarma.
